sub:assertion {
d:DB00603 v:identifier "DB00603" ;
v:namespace "drugbank" ;
v:uri "http://bio2rdf.org/drugbank:DB00603" ;
v:x-identifiers.org <
http://identifiers.org/drugbank/DB00603> ;
dv:drugbank-id "APRD00627" , "DB00603" ;
dv:x-ahfs <
http://bio2rdf.org/ahfs:68:32.00> ;
dv:x-cas <
http://bio2rdf.org/cas:71-58-9> ;
dv:x-chebi <
http://bio2rdf.org/chebi:6715> ;
dv:x-dpd <
http://bio2rdf.org/dpd:2247583> ;
dv:x-gtp <
http://bio2rdf.org/gtp:2879> ;
dv:x-iuphar <
http://bio2rdf.org/iuphar:2879> ;
dv:x-kegg <
http://bio2rdf.org/kegg:C08150> , <
http://bio2rdf.org/kegg:D00951> ;
dv:x-ndc <
http://bio2rdf.org/ndc:0009-0064-06> ;
dv:x-pharmgkb <
http://bio2rdf.org/pharmgkb:PA450344> ;
dv:x-wikipedia <
http://bio2rdf.org/wikipedia:Medroxyprogesterone> ;
dct:description """Medroxyprogesterone acetate (INN, USAN, BAN), also known as 17α-hydroxy-6α-methylprogesterone acetate, and commonly abbreviated as MPA, is a steroidal progestin, a synthetic variant of the human hormone progesterone. It is used as a contraceptive, in hormone replacement therapy and for the treatment of endometriosis as well as several other indications.
MPA is a more potent derivative of its parent compound medroxyprogesterone (MP). While medroxyprogesterone is sometimes used as a synonym for medroxyprogesterone acetate, what is normally being administered is MPA and not MP. [Wikipedia]"""@en ;
dct:identifier "drugbank:DB00603" ;
dct:title "Medroxyprogesterone Acetate"@en ;
a dv:Drug ;
rdfs:label "Medroxyprogesterone Acetate [drugbank:DB00603]"@en ;
rdfs:seeAlso <
http://www.drugbank.ca/drugs/DB00603> , <
http://www.drugs.com/medroxyprogesterone.html> , <
http://www.rxlist.com/cgi/generic/medrox.htm> .
}